首页> 外国专利> Marker and immunological reagent for dialysis-related amyloidosis, diabetes mellitus and diabetes mellitus complications

Marker and immunological reagent for dialysis-related amyloidosis, diabetes mellitus and diabetes mellitus complications

机译:透析相关淀粉样变性病,糖尿病和糖尿病并发症的标志物和免疫试剂

摘要

An immunological reagent for diagnosis of or the evaluation of the effect of a medicine for dialysis-related amyloidosis, comprising an antibody which reacts specifically with a carboxymethylated α-amino acid, a carboxymethylated protein, or a carboxymethylated peptide; an immunological reagent for diagnosis of or the evaluation of the effect of a medicine for diabetes mellitus and diabetes mellitus complications, comprising an antibody which reacts specifically with an Nα-carboxymethylated α-amino acid, an Nα-carboxymethylated protein, or an Nα-carboxymethylated peptide; a carboxymethylated α-amino acid, a carboxymethylated protein, or a carboxymethylated peptide as a marker for dialysis-related amyloidosis; or an Nα-carboxymethylated α-amino acid, an Nα-carboxymethylated protein, or an Nα-carboxymethylated peptide as a marker for diabetes mellitus or diabetes mellitus complications.
机译:一种用于诊断或评估与透析有关的淀粉样变性药物的免疫学试剂,其包含与羧甲基化的α-氨基酸,羧甲基化的蛋白质或羧甲基化的肽特异性反应的抗体;用于诊断或评估糖尿病和糖尿病并发症的药物的免疫学试剂,其包含与N α-羧甲基化的α-氨基酸,N < Sup>α-羧甲基化的蛋白质或N α-羧甲基化的肽;羧甲基化的α-氨基酸,羧甲基化的蛋白质或羧甲基化的肽作为透析相关淀粉样变性病的标记物;或N α-羧甲基化的α-氨基酸,N α-羧甲基化的蛋白质或N α-羧甲基化的肽作为标记糖尿病或糖尿病并发症。

著录项

  • 公开/公告号EP0840126B1

    专利类型

  • 公开/公告日2004-09-01

    原文格式PDF

  • 申请/专利权人 TOKUYAMA CORP;

    申请/专利号EP19970308643

  • 申请日1997-10-29

  • 分类号G01N33/68;

  • 国家 EP

  • 入库时间 2022-08-21 22:58:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号